FDA APPROVES IMDELLTRA™ (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER - Amgen amgen.com Submitted by amgencom8724 on May 17, 2024 at 10:58 PM in business No comments 16